Search Results

There are 4851 results for: content related to: Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia

  1. You have free access to this content
    Proteomic analysis of striatal proteins in the rat model of l-DOPA-induced dyskinesia

    Journal of Neurochemistry

    Volume 102, Issue 4, August 2007, Pages: 1395–1409, Barbara Valastro, Andrzej Dekundy, Morten Krogh, Martin Lundblad, Peter James, Wojciech Danysz, Guenter Quack and Maria Angela Cenci

    Article first published online : 26 MAY 2007, DOI: 10.1111/j.1471-4159.2007.04655.x

  2. L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum

    Journal of Neuroscience Research

    Yong Wang, Hui Sheng Wang, Tao Wang, Chen Huang and Jian Liu

    Article first published online : 26 JUN 2014, DOI: 10.1002/jnr.23439

  3. You have free access to this content
    Role of striatal l-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats

    Journal of Neurochemistry

    Volume 96, Issue 6, March 2006, Pages: 1718–1727, Manolo Carta, Hanna S. Lindgren, Martin Lundblad, Roberto Stancampiano, Fabio Fadda and M. A. Cenci

    Article first published online : 3 MAR 2006, DOI: 10.1111/j.1471-4159.2006.03696.x

  4. You have free access to this content
    Chronic intermittent L-DOPA treatment induces changes in dopamine release

    Journal of Neurochemistry

    Volume 108, Issue 4, February 2009, Pages: 998–1008, Martin Lundblad, Sara Af Bjerkén, M. Angela Cenci, Francois Pomerleau, Greg A. Gerhardt and Ingrid Strömberg

    Article first published online : 13 DEC 2008, DOI: 10.1111/j.1471-4159.2008.05848.x

  5. You have free access to this content
    l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson’s disease: temporal and quantitative relationship to the expression of dyskinesia

    Journal of Neurochemistry

    Volume 112, Issue 6, March 2010, Pages: 1465–1476, Hanna S. Lindgren, Daniel R. Andersson, Sören Lagerkvist, Hans Nissbrandt and M. Angela Cenci

    Article first published online : 24 DEC 2009, DOI: 10.1111/j.1471-4159.2009.06556.x

  6. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA

    European Journal of Neuroscience

    Volume 10, Issue 8, August 1998, Pages: 2694–2706, M. A. Cenci, C. S. Lee and A. Björklund

    Article first published online : 3 FEB 2003, DOI: 10.1046/j.1460-9568.1998.00285.x

  7. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  8. You have free access to this content
    Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia

    Journal of Neurochemistry

    Volume 118, Issue 1, July 2011, Pages: 12–23, Nina Nevalainen, Sara af Bjerkén, Martin Lundblad, Greg A. Gerhardt and Ingrid Strömberg

    Article first published online : 25 MAY 2011, DOI: 10.1111/j.1471-4159.2011.07292.x

  9. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  10. You have free access to this content
    Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels

    Journal of Neurochemistry

    Volume 118, Issue 6, September 2011, Pages: 1043–1055, Simone Bido, Matteo Marti and Michele Morari

    Article first published online : 5 AUG 2011, DOI: 10.1111/j.1471-4159.2011.07376.x

  11. Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission

    European Journal of Neuroscience

    Volume 24, Issue 6, September 2006, Pages: 1802–1814, Paolo Gubellini, Alexandre Eusebio, Abid Oueslati, Christophe Melon, Lydia Kerkerian-Le Goff and Pascal Salin

    Article first published online : 21 SEP 2006, DOI: 10.1111/j.1460-9568.2006.05047.x

  12. You have free access to this content
    Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson’s disease

    Journal of Neurochemistry

    Volume 101, Issue 2, April 2007, Pages: 483–497, Flora Mela, Matteo Marti, Andrzej Dekundy, Wojciech Danysz, Michele Morari and M. Angela Cenci

    Article first published online : 22 JAN 2007, DOI: 10.1111/j.1471-4159.2007.04456.x

  13. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms

    European Journal of Neuroscience

    Volume 28, Issue 5, September 2008, Pages: 941–950, M. Giorgi, V. D’Angelo, Z. Esposito, V. Nuccetelli, R. Sorge, A. Martorana, A. Stefani, G. Bernardi and G. Sancesario

    Article first published online : 20 AUG 2008, DOI: 10.1111/j.1460-9568.2008.06387.x

  14. Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys

    Annals of Neurology

    Volume 59, Issue 2, February 2006, Pages: 282–288, Pershia Samadi, Laurent Grégoire, Claude Rouillard, Paul J. Bédard, Thérèse Di Paolo and Daniel Lévesque

    Article first published online : 25 JAN 2006, DOI: 10.1002/ana.20738

  15. You have free access to this content
    Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia

    Annals of Neurology

    Volume 57, Issue 1, January 2005, Pages: 17–26, Incarnation Aubert, Céline Guigoni, Kerstin Håkansson, Qin Li, Sandra Dovero, Nicole Barthe, Bernard H. Bioulac, Christian E. Gross, Gilberto Fisone, Bertrand Bloch and Erwan Bezard

    Article first published online : 27 OCT 2004, DOI: 10.1002/ana.20296

  16. Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment

    Movement Disorders

    Volume 25, Issue 11, 15 August 2010, Pages: 1568–1576, Pauline Belujon, Daniel J. Lodge and Anthony A. Grace

    Article first published online : 9 JUL 2010, DOI: 10.1002/mds.23245

  17. Swallowing abnormalities and dyskinesia in Parkinson's disease

    Movement Disorders

    Volume 20, Issue 4, April 2005, Pages: 457–462, Francisca Sueli Monte, Francisco Pereira da Silva-Júnior, Pedro Braga-Neto, Miguel Ângelo Nobre e Souza and Veralice Meireles Sales de Bruin

    Article first published online : 29 DEC 2004, DOI: 10.1002/mds.20342

  18. You have free access to this content
    The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy

    Developmental Medicine & Child Neurology

    Volume 54, Issue 3, March 2012, Pages: 278–283, ELEGAST MONBALIU, ELS ORTIBUS, JOS de CAT, BERNARD DAN, LIEVE HEYRMAN, PETER PRINZIE, PAUL de COCK and HILDE FEYS

    Article first published online : 16 JAN 2012, DOI: 10.1111/j.1469-8749.2011.04209.x

  19. You have free access to this content
    The α2 adrenoceptor antagonist idazoxan alleviates l-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats

    Journal of Neurochemistry

    Volume 112, Issue 2, January 2010, Pages: 444–452, Kerstin Buck, Patrizia Voehringer and Boris Ferger

    Article first published online : 6 NOV 2009, DOI: 10.1111/j.1471-4159.2009.06482.x

  20. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning

    European Journal of Neuroscience

    Volume 22, Issue 1, July 2005, Pages: 283–287, Céline Guigoni, Sandra Dovero, Incarnation Aubert, Qin Li, Bernard H. Bioulac, Bertrand Bloch, Eugenia V. Gurevich, Christian E. Gross and Erwan Bezard

    Article first published online : 19 JUL 2005, DOI: 10.1111/j.1460-9568.2005.04196.x